AKT1 and prostate cancer: The PI3K pathway appears to be critical in the development of CRPC: in vitro data suggest that overexpression and activation of AKT can trigger prostate cancer androgen escape via altered sensitivity and activation of AR (Edwards and Bartlett, 2005).